Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a

Insulet Corporation (PODD) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Insulet Corporation (PODD) trades at a EV/FCF of 38.4×. Over the past ten years it has ranged from −1,183× (November 2020) to 2,571× (December 2015); the current reading is higher than 77% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 57.8× (8.53%)
FY2024 63.2× (84.92%)
FY2023 419× —
FY2022 −538× —
FY2021 −96.9× —
FY2020 −202× —
FY2019 −150× —
FY2018 −38.5× —
FY2017 −128× —
FY2016 −354× —

Quarterly newest first

Period EV/FCF Change
Jun 2026 41.3× 5.64%
Mar 2026 39.1× (32.41%)
Dec 2025 57.8× 7.17%
Sep 2025 53.9× (5.55%)
42 more quarters

Against its own ten years

Low −1,183× High 2,571×
Ten-year median −93.9×
Current reading's percentile 77

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on PODD